Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -29.22%1.7M | -68.35%7.81M | 1.16M | 115.48%1.6M | 115.37%2.65M | -86.29%2.4M | 10.93%24.67M | 68.86%743K | -57.91%22.24M | 3.07M |
| Cost of revenue | -103.50%-52K | -90.57%2.15M | 217K | -119.41%-164K | -46.19%607K | -90.47%1.49M | 16.69%22.77M | 409.04%845K | -55.31%19.52M | 2.62M |
| Gross profit | 91.89%1.75M | 198.24%5.66M | 941K | 1,830.39%1.77M | 1,901.96%2.04M | -51.97%912K | -30.35%1.9M | -137.23%-102K | -70.29%2.73M | 450K |
| Operating expense | 172.78%11.22M | -62.51%12.27M | 799K | 7.03%3.62M | 41.48%3.74M | 129.73%4.11M | 3,363.15%32.73M | -58.49%3.39M | -102.11%-1M | 2.04M |
| Selling and administrative expenses | 186.74%11.05M | -48.46%8.89M | --308K | -58.93%1.24M | -15.71%3.48M | 24.56%3.86M | 46.67%17.24M | 26.37%3.02M | -70.07%11.76M | --2.14M |
| -General and administrative expense | 186.74%11.05M | -48.46%8.89M | --308K | -58.93%1.24M | -15.71%3.48M | 24.56%3.86M | 46.67%17.24M | 26.37%3.02M | -70.07%11.76M | --2.14M |
| Depreciation and amortization | -35.69%200K | --3.49M | --476K | 566.48%2.43M | -27.58%281K | -25.06%311K | ---- | -51.85%364K | --1.6M | --39K |
| -Depreciation | -35.69%200K | --3.49M | --476K | 566.48%2.43M | -27.58%281K | -25.06%311K | ---- | -51.85%364K | --1.6M | --39K |
| Other operating expenses | ---- | ---- | --15K | ---- | ---- | ---- | --29.51M | ---- | ---- | ---- |
| Total other operating income | -38.46%32K | -99.22%110K | ---- | 1,400.00%45K | -98.51%28K | -99.70%52K | -2.33%14.02M | --3K | 601.99%14.36M | --137K |
| Operating profit | -195.82%-9.47M | 78.56%-6.61M | 142K | 46.72%-1.86M | 33.29%-1.69M | -120.35%-3.2M | -927.03%-30.83M | 55.75%-3.49M | 109.70%3.73M | -1.59M |
| Net non-operating interest income (expenses) | -324K | -61.44%-1.32M | -126K | -573.25%-1.06M | 22.47%-138K | 0 | -53.81%-818.25K | -3.97%-157K | 73.21%-532K | -17K |
| Non-operating interest expense | --324K | 61.44%1.32M | --126K | 573.25%1.06M | -22.47%138K | --0 | 53.81%818.25K | 3.97%157K | -73.21%532K | --17K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -205.93%-9.8M | 74.94%-7.93M | 16K | 20.01%-2.92M | 32.58%-1.83M | -120.59%-3.2M | -1,090.30%-31.65M | 54.63%-3.64M | 107.91%3.2M | -1.61M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | -332.85K | 0 | 0 | 0 |
| Net income | -205.93%-9.8M | 74.67%-7.93M | 16K | 20.01%-2.92M | 32.58%-1.83M | -120.59%-3.2M | -1,079.88%-31.32M | 54.63%-3.64M | 108.16%3.2M | -1.61M |
| Net income continuous operations | -205.93%-9.8M | 74.67%-7.93M | --16K | 20.01%-2.92M | 32.58%-1.83M | -120.59%-3.2M | -1,079.88%-31.32M | 54.63%-3.64M | 108.16%3.2M | ---1.61M |
| Noncontrolling interests | 57.96%-449K | -435.79%-1.32M | 844K | -1.05M | -1,233.33%-40K | -130.91%-1.07M | -245.43K | 0 | 0 | 0 |
| Net income attributable to the company | -338.00%-9.35M | 78.70%-6.62M | -828K | 48.85%-1.86M | 33.98%-1.79M | -117.64%-2.13M | -1,072.20%-31.07M | 20.44%-3.64M | 109.07%3.2M | -1.61M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -338.00%-9.35M | 78.70%-6.62M | -828K | 48.85%-1.86M | 33.98%-1.79M | -117.64%-2.13M | -1,072.20%-31.07M | 20.44%-3.64M | 109.07%3.2M | -1.61M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -337.73%-0.0228 | 82.00%-0.0161 | -0.002 | 65.87%-0.0045 | 61.06%-0.0044 | -110.34%-0.0052 | -816.00%-0.0895 | 30.00%-0.0133 | 108.15%0.0125 | -0.0063 |
| Diluted earnings per share | -337.73%-0.0228 | 82.00%-0.0161 | -0.002 | 65.87%-0.0045 | 61.06%-0.0044 | -110.34%-0.0052 | -816.00%-0.0895 | 30.00%-0.0133 | 108.15%0.0125 | -0.0063 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.